Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Genmab
Genmab
Incyte Corporation
National Cancer Institute (NCI)
National Health Research Institutes, Taiwan
Telix Pharmaceuticals (Innovations) Pty Limited